Novavax, Inc. financial statements
Novavax, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 1.12B | 10-K |
| Net income | USD 440.3M | 10-K |
| Cash and equivalents | USD 240.63M | 10-Q |
| Total debt | USD 244.21M | 10-Q |